New brain & blood test combo may spot deadly pregnancy complication earlier
NCT ID NCT02578810
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a brain wave monitor (BIS) and two blood tests (sFIT/PIGF ratio and adrenomedullin) can more accurately grade the severity of preeclampsia and eclampsia in pregnant women. Researchers will enroll 48 participants to see if these tools can predict risk better than current methods. The goal is to help doctors catch dangerous cases earlier and improve mother and baby outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical Ethics Committee, University Malaya Medical Centre
RECRUITINGKuala Lumpur, Malaysia
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- Could pregnant women safely stop aspirin earlier? new trial investigates
- Eye test and blood markers could spot dangerous pregnancy condition earlier
- Pregnancy complication linked to midlife brain changes?
- A simple nudge after childbirth could transform lifelong health for moms with chronic conditions
- Heart and lung changes in pregnancy could reveal hidden clues to preeclampsia